FDA Opened 16 Health Care Fraud Investigations In FY 2011; DoJ Net Tops $4 Billion
This article was originally published in The Pink Sheet Daily
Executive Summary
HHS and the Department of Justice note actions taken last year in their Health Care Fraud and Abuse Control Program Annual Report for fiscal year 2011; enforcement actions net a record sum.
You may also be interested in...
FDA Is Pursuing Its Own Pharma Fraud Investigations; DoJ Nets $2.5 Bil. In FY 2010
One sign that the government is zealously going after the pharmaceutical industry for health care fraud is the line up of criminal investigations FDA has initiated.
AWP Litigation: Three More Companies Ink Deals With DoJ; Roxane Sets A Record
The heavy docket of average wholesale price cases got a bit lighter as three pharma companies agreed to pay $421 million to settle claims they inflated the AWP of numerous drugs, thus increasing reimbursement levels.
GMP Violations At GSK's Former Puerto Rico Plant Are Basis Of $750 Million DoJ Settlement
In the first False Claims Act case alleging cGMP violations the government cites microbial contamination, split tablets and product mix-ups.